127 related articles for article (PubMed ID: 33166601)
1. Centromere protein F is identified as a novel therapeutic target by genomics profile and contributing to the progression of pancreatic cancer.
Chen H; Wang X; Wu F; Mo X; Hu C; Wang M; Xu H; Yao C; Xia H; Lan L
Genomics; 2021 Jan; 113(1 Pt 2):1087-1095. PubMed ID: 33166601
[TBL] [Abstract][Full Text] [Related]
2. Centromere protein F promotes progression of hepatocellular carcinoma through ERK and cell cycle-associated pathways.
Chen H; Wu F; Xu H; Wei G; Ding M; Xu F; Deivasigamani A; Zhou G; Hui KM; Xia H
Cancer Gene Ther; 2022 Jul; 29(7):1033-1042. PubMed ID: 34857915
[TBL] [Abstract][Full Text] [Related]
3. Centromere protein F (CENPF), a microtubule binding protein, modulates cancer metabolism by regulating pyruvate kinase M2 phosphorylation signaling.
Shahid M; Lee MY; Piplani H; Andres AM; Zhou B; Yeon A; Kim M; Kim HL; Kim J
Cell Cycle; 2018; 17(24):2802-2818. PubMed ID: 30526248
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of CENPF is associated with progression and poor prognosis of lung adenocarcinoma.
Li MX; Zhang MY; Dong HH; Li AJ; Teng HF; Liu AL; Xu N; Qu YQ
Int J Med Sci; 2021; 18(2):494-504. PubMed ID: 33390818
[No Abstract] [Full Text] [Related]
5. Downregulation of CENPF Remodels Prostate Cancer Cells and Alters Cellular Metabolism.
Shahid M; Kim M; Lee MY; Yeon A; You S; Kim HL; Kim J
Proteomics; 2019 Jun; 19(11):e1900038. PubMed ID: 30957416
[TBL] [Abstract][Full Text] [Related]
6. CENPF/CDK1 signaling pathway enhances the progression of adrenocortical carcinoma by regulating the G2/M-phase cell cycle.
Huang YG; Li D; Wang L; Su XM; Tang XB
J Transl Med; 2022 Feb; 20(1):78. PubMed ID: 35123514
[TBL] [Abstract][Full Text] [Related]
7. Enhanced expression of centromere protein F predicts clinical progression and prognosis in patients with prostate cancer.
Zhuo YJ; Xi M; Wan YP; Hua W; Liu YL; Wan S; Zhou YL; Luo HW; Wu SL; Zhong WD; Wu CL
Int J Mol Med; 2015 Apr; 35(4):966-72. PubMed ID: 25647485
[TBL] [Abstract][Full Text] [Related]
8. Calreticulin promotes EMT in pancreatic cancer via mediating Ca
Sheng W; Wang G; Tang J; Shi X; Cao R; Sun J; Lin YH; Jia C; Chen C; Zhou J; Dong M
J Exp Clin Cancer Res; 2020 Oct; 39(1):209. PubMed ID: 33028359
[TBL] [Abstract][Full Text] [Related]
9. miR-383-5p inhibits human malignant melanoma cells function via targeting CENPF.
Xu H; Zhu X; Shi L; Lin N; Li X
Reprod Biol; 2021 Sep; 21(3):100535. PubMed ID: 34274651
[TBL] [Abstract][Full Text] [Related]
10. TUFT1 regulates metastasis of pancreatic cancer through HIF1-Snail pathway induced epithelial-mesenchymal transition.
Zhou B; Zhan H; Tin L; Liu S; Xu J; Dong Y; Li X; Wu L; Guo W
Cancer Lett; 2016 Nov; 382(1):11-20. PubMed ID: 27566398
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the oncogenic function of centromere protein F in hepatocellular carcinoma.
Dai Y; Liu L; Zeng T; Zhu YH; Li J; Chen L; Li Y; Yuan YF; Ma S; Guan XY
Biochem Biophys Res Commun; 2013 Jul; 436(4):711-8. PubMed ID: 23791740
[TBL] [Abstract][Full Text] [Related]
12. CUL4B promotes metastasis and proliferation in pancreatic cancer cells by inducing epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway.
He YM; Xiao YS; Wei L; Zhang JQ; Peng CH
J Cell Biochem; 2018 Jul; 119(7):5308-5323. PubMed ID: 29274277
[TBL] [Abstract][Full Text] [Related]
13. Girdin interaction with vimentin induces EMT and promotes the growth and metastasis of pancreatic ductal adenocarcinoma.
Wang W; Chen H; Gao W; Wang S; Wu K; Lu C; Luo X; Li L; Yu C
Oncol Rep; 2020 Aug; 44(2):637-649. PubMed ID: 32467989
[TBL] [Abstract][Full Text] [Related]
14. MiR-301a transcriptionally activated by HIF-2α promotes hypoxia-induced epithelial-mesenchymal transition by targeting TP63 in pancreatic cancer.
Zhang KD; Hu B; Cen G; Yang YH; Chen WW; Guo ZY; Wang XF; Zhao Q; Qiu ZJ
World J Gastroenterol; 2020 May; 26(19):2349-2373. PubMed ID: 32476798
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of CENPF inhibits the progression of lung adenocarcinoma mediated by ERβ2/5 pathway.
Hexiao T; Yuquan B; Lecai X; Yanhong W; Li S; Weidong H; Ming X; Xuefeng Z; Gaofeng P; Li Z; Minglin Z; Zheng T; Zetian Y; Xiao Z; Yi C; Lanuti M; Jinping Z
Aging (Albany NY); 2021 Jan; 13(2):2604-2625. PubMed ID: 33428600
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of CBX3 in Pancreatic Adenocarcinoma Promotes Cell Cycle Transition-Associated Tumor Progression.
Chen LY; Cheng CS; Qu C; Wang P; Chen H; Meng ZQ; Chen Z
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29903985
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-10a promotes epithelial-to-mesenchymal transition and stemness maintenance of pancreatic cancer stem cells via upregulating the Hippo signaling pathway through WWC2 inhibition.
Wang C; Yin W; Liu H
J Cell Biochem; 2020 Nov; 121(11):4505-4521. PubMed ID: 32542845
[TBL] [Abstract][Full Text] [Related]
18. HnRNPR-CCNB1/CENPF axis contributes to gastric cancer proliferation and metastasis.
Chen EB; Qin X; Peng K; Li Q; Tang C; Wei YC; Yu S; Gan L; Liu TS
Aging (Albany NY); 2019 Sep; 11(18):7473-7491. PubMed ID: 31527303
[TBL] [Abstract][Full Text] [Related]
19. Lost miR-141 and upregulated TM4SF1 expressions associate with poor prognosis of pancreatic cancer: regulation of EMT and angiogenesis by miR-141 and TM4SF1 via AKT.
Xu D; Yang F; Wu K; Xu X; Zeng K; An Y; Xu F; Xun J; Lv X; Zhang X; Yang X; Xu L
Cancer Biol Ther; 2020 Apr; 21(4):354-363. PubMed ID: 31906774
[No Abstract] [Full Text] [Related]
20. LncRNA MCM3AP-AS1 promotes breast cancer progression via modulating miR-28-5p/CENPF axis.
Chen Q; Xu H; Zhu J; Feng K; Hu C
Biomed Pharmacother; 2020 Aug; 128():110289. PubMed ID: 32485570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
